Canada · Recalls · Issue #4 · 28/09 – 04/10
Canada recalls selected Sanofi insulin pens and cartridges
Health Canada reports a recall of certain Sanofi-Aventis Canada insulin pens and cartridges shipped on specific dates in July and August 2026. Only some units within the listed lots are affected.
What the primary source says
Health Canada reports a recall of certain Sanofi-Aventis Canada insulin pens and cartridges shipped on specific dates in July and August 2026. Only some units within the listed lots are affected. A listed lot number alone is not proof that a unit is affected. Ask the dispensing provider to check it; if affected or uncertain, do not use it and obtain a replacement. Anyone who used an affected unit should monitor blood sugar more closely and consult a healthcare professional about symptoms or concerns.
Source: Health Canada, recall RA-82686. Contains information licensed under the Open Government Licence – Canada. https://open.canada.ca/en/open-government-licence-canada
Why it matters
The useful distinction
The recall is limited to named units and lots, so online and cross-border buyers should check the exact packaging and obtain confirmation from the supplying pharmacy or clinic.
This briefing is an independent summary of the evidence sources below. Context-only links are not used as factual authority. It does not establish that a product, organisation or listing is unsafe, unlawful or non-compliant beyond what the evidence reports.